Edition:
United Kingdom

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

132.50USD
16 Jul 2019
Change (% chg)

$-2.21 (-1.64%)
Prev Close
$134.71
Open
$132.91
Day's High
$133.83
Day's Low
$131.78
Volume
2,338,171
Avg. Vol
2,027,191
52-wk High
$148.97
52-wk Low
$122.00

Select another date:

Tue, Jul 16 2019

Photo

J&J warns of hit from generic drugs in third quarter, shares fall

Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results, sending shares down 1.4% in noon trading.

J&J warns of hit from generic drugs in third quarter, shares fall

Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results, sending shares down 1.4% in noon trading.

UPDATE 3-J&J warns of hit from generic drugs in third quarter, shares fall

July 16 Johnson & Johnson on Tuesday boosted its 2019 sales forecast amid robust demand for its cancer drugs, but warned that competition from generic and copycat drugs could impact its third-quarter results, sending shares down 1.4% in noon trading.

Johnson & Johnson quarterly profit jumps 41.8%

July 16 Johnson & Johnson reported a 41.8% rise in second-quarter profit on Tuesday, helped by its pharmaceuticals business.

Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end

NORMAN, Okla. Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible for fueling the U.S. opioid epidemic in the first trial to result from lawsuits over the crisis.

Opioid 'kingpin' J&J fuelled epidemic, Oklahoma argues at trial's end

NORMAN, Okla. Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible for fuelling the U.S. opioid epidemic in the first trial to result from lawsuits over the crisis.

CORRECTED-UPDATE 2-Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic

NORMAN, Okla., July 15 Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible for fueling the U.S. opioid epidemic in the first trial to result from lawsuits over the crisis.

Oklahoma, J&J to wrap up first trial over opioid crisis

July 15 Oklahoma's attorney general is expected on Monday to urge a judge to find Johnson & Johnson responsible for flooding the market with painkillers and fueling the U.S. opioid epidemic, as the first trial in nationwide litigation over the drug crisis comes to an end.

J&J faces U.S. criminal probe related to baby powder - Bloomberg

The U.S. Justice Department is pursuing a criminal probe into whether Johnson & Johnson lied about potential cancer risks of its talcum powder and has convened a grand jury in Washington, Bloomberg reported on Friday, citing people with knowledge of the matter.

J&J faces U.S. criminal probe related to baby powder - Bloomberg

The U.S. Justice Department is pursuing a criminal probe into whether Johnson & Johnson lied about potential cancer risks of its talcum powder and has convened a grand jury in Washington, Bloomberg reported on Friday, citing people with knowledge of the matter.

Select another date: